Vitruvian Partners LLP Rx Sight, Inc. Transaction History
Vitruvian Partners LLP
- $99.5 Million
- Q2 2025
A detailed history of Vitruvian Partners LLP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Vitruvian Partners LLP holds 230,743 shares of RXST stock, worth $2.03 Million. This represents 3.01% of its overall portfolio holdings.
Number of Shares
230,743
Previous 230,743
-0.0%
Holding current value
$2.03 Million
Previous $5.83 Million
48.52%
% of portfolio
3.01%
Previous 5.56%
Shares
2 transactions
Others Institutions Holding RXST
# of Institutions
188Shares Held
36.5MCall Options Held
42.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA3.7MShares$32.6 Million1.05% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$21.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$20.1 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$15.6 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.32MShares$11.6 Million0.01% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $243M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...